VIENNA, Austria, January 30 /PRNewswire/ -- EUCODIS Bioscience, a company developing enzymes for the chemical industry, announced today that Thomas Fischer has joined the company as Chief Financial Officer.
"We are excited about the wealth of experience that Thomas brings to EUCODIS Bioscience," said Rudy Pandjaitan, Ph.D., CEO of EUCODIS Bioscience. "His strong background in the life science industry and his close relations with the investment community will be a tremendous asset and help drive the future financial growth of the Company. Thomas joins EUCODIS Bioscience as the Company is launching its first commercial enzyme and is expanding the scope of its industrial collaborations from its current European focus into the US and Asian markets."
Most recently Mr. Fischer served as Chief Financial Officer of Austrianova, a clinical stage biopharmaceutical company that he co-founded in 2001. In this responsibility he successfully raised more than 30 million Euros in two private financing rounds. Prior to that he held senior positions at Aventis CropScience, Germany, and at Nycomed Pharma East Europe/CIS. Before joining the life science industry, Mr. Fischer spent several years in the European consumer goods and construction industries.
Mr. Fischer holds an M.B.A. from Vienna University of Economics and Business Administration, Austria, where he also received his M.Sc.
About EUCODIS Bioscience
EUCODIS Bioscience GmbH develops enzymes and biocatalytic processes that enable the chemical, pharmaceutical and other industries to establish critical manufacturing processes and to generate superior products.
Based on its proven proprietary technology and led by an experienced management team, EUCODIS Bioscience provides products and services that help its customers to improve efficiencies and to meet growing environmental requirements.
The Company commercializes its enzyme expertise and its versatile and powerful technology in development projects with industrial partners. Current partners include industry leaders such as GlaxoSmithKline, Henkel, and Lohmann Animal Health.
The Company was founded in 2007, as a demerger of the "white biotech" business unit of Eucodis GmbH, a company founded in 2004. The Company is headquartered in Austria, Europe, with subsidiaries in France and Germany.
For more information, please visithttp://www.eucodisbioscience.com Company contact: Rudy Pandjaitan, PhD CEO EUCODIS Bioscience Brunner Strasse 59 A-1230 Vienna AUSTRIA +43-1-86634-9241 email@example.com Media Contact: Frank Butschbacher Investor Relations & Communications +43-650-7844940 firstname.lastname@example.org http://www.butschbacher.net
|SOURCE EUCODIS Bioscience|
Copyright©2009 PR Newswire.
All rights reserved